Recombinant Bifidobacterium adolescentis oligosaccharide reducing-end xylanase 8A produced by Escherichia coli, hydrolyzes 1-4-β-xylose residues specifically from the reducing end of oligosaccharides.
Expression System
Escherichia coli
Species
Bifidobacterium adolescentis
Concentration
1 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Oligosaccharide reducing-end xylanases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Bifidobacterium adolescentis oligosaccharide reducing-end xylanase 8A can be used for the hydrolysis of oligosaccharides. It has the ability to hydrolyze 4-nitrophenyl-α-L-arabinofuranoside and arabinoxylans.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
